Dr. Claire M. Storey is a patent agent in the Century City office of Wilson Sonsini Goodrich & Rosati, where her work focuses on patents and innovations related to biotechnology and the life sciences. Her scientific expertise includes cancer therapeutics, radiopharmaceuticals, gene therapy, and immuno-oncology.
Prior to joining the firm, Claire obtained her Ph.D. in the laboratory of Dr. David Ulmert at the University of California, Los Angeles, where her doctoral research focused on the development of radiopharmaceuticals for therapeutic and diagnostic applications. She also conducted research at Stanford University, where she established a novel model of neuroendocrine tumorigenesis, and at the University of North Carolina at Chapel Hill, where she characterized viral capsids for gene therapy. Claire has published in each of these fields.
Dr. Claire M. Storey is a patent agent in the Century City office of Wilson Sonsini Goodrich & Rosati, where her work focuses on patents and innovations related to biotechnology and the life sciences. Her scientific expertise includes cancer therapeutics, radiopharmaceuticals, gene therapy, and immuno-oncology.
Prior to joining the firm, Claire obtained her Ph.D. in the laboratory of Dr. David Ulmert at the University of California, Los Angeles, where her doctoral research focused on the development of radiopharmaceuticals for therapeutic and diagnostic applications. She also conducted research at Stanford University, where she established a novel model of neuroendocrine tumorigenesis, and at the University of North Carolina at Chapel Hill, where she characterized viral capsids for gene therapy. Claire has published in each of these fields.
- Ph.D., Molecular and Medical Pharmacology, University of California, Los Angeles, 2024
- B.S., Biology, University of North Carolina at Chapel Hill, 2017
- U.S. Patent and Trademark Office
- Ph.D., Molecular and Medical Pharmacology, University of California, Los Angeles, 2024
- B.S., Biology, University of North Carolina at Chapel Hill, 2017
- U.S. Patent and Trademark Office
Select Publications
- Lead author with M. Altai, M. Bicak, D.R. Veach, et al., “Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response,” Molecular Cancer Research, 2023
- Co-author with N. Armstrong, S.E. Noll, K. Margulis, et al., “SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas,” Cell Reports, 2022
- Co-author with D.R. Veach, K. Luckerath, K. Braun, et al., ”PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates,” Clinical Cancer Research, 2021
- Co-author with B.H. Albright, G. Murlidharan, R.M. Castellanos-Rivera, et al., “Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier,” Molecular Therapy, 2018
Select Publications
- Lead author with M. Altai, M. Bicak, D.R. Veach, et al., “Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response,” Molecular Cancer Research, 2023
- Co-author with N. Armstrong, S.E. Noll, K. Margulis, et al., “SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas,” Cell Reports, 2022
- Co-author with D.R. Veach, K. Luckerath, K. Braun, et al., ”PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates,” Clinical Cancer Research, 2021
- Co-author with B.H. Albright, G. Murlidharan, R.M. Castellanos-Rivera, et al., “Mapping the Structural Determinants Required for AAVrh.10 Transport across the Blood-Brain Barrier,” Molecular Therapy, 2018
Biological Sciences and Biotechnology
- Antibody
- Cancer biology
- Cancer therapeutics
- Immuno-oncology
Therapeutics and Drug Discovery
- CRISPR
- Drug conjugates
- Peptide therapeutics
- Pharmacology
Genomics and Data Analysis
- Next-generation sequencing
- Sequencing
- Single-cell sequencing
Biological Sciences and Biotechnology
- Antibody
- Cancer biology
- Cancer therapeutics
- Immuno-oncology
Therapeutics and Drug Discovery
- CRISPR
- Drug conjugates
- Peptide therapeutics
- Pharmacology
Genomics and Data Analysis
- Next-generation sequencing
- Sequencing
- Single-cell sequencing
- Privacy Policy
- Terms of Use
- Accessibility